Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

JUAN PABLO SARMIENTO

Allopathic & Osteopathic Physicians Internal Medicine Pulmonary Disease

NPI
1568625432
CMS profile
521804
Location
MCALLEN, TX

General Payments · PY2018–2024

$10,432.44

  • Reported across 263 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$801.74

38 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $801.74 38

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $734.65 51
PY2019 $753.30 53
PY2020 $552.34 36
PY2021 $353.29 10
PY2022 $490.54 29
PY2023 $6,746.58 46
PY2024 $801.74 38

Payment records · PY2024 (38)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
AstraZeneca Pharmaceuticals LP $16.64 03/06/2024 Food and Beverage Undisputed 01/23/2026 1104660401 CMS
AstraZeneca Pharmaceuticals LP $21.77 03/06/2024 Food and Beverage Undisputed 01/23/2026 1105671663 CMS
AstraZeneca Pharmaceuticals LP $23.35 04/29/2024 Food and Beverage Undisputed 01/23/2026 1104694484 CMS
AstraZeneca Pharmaceuticals LP $28.66 06/26/2024 Food and Beverage Undisputed 01/23/2026 1104490362 CMS
AstraZeneca Pharmaceuticals LP $18.13 07/24/2024 Food and Beverage Undisputed 01/23/2026 1104586174 CMS
AstraZeneca Pharmaceuticals LP $29.27 09/16/2024 Food and Beverage Undisputed 01/23/2026 1104415993 CMS
AstraZeneca Pharmaceuticals LP $20.27 10/14/2024 Food and Beverage Undisputed 01/23/2026 1105513811 CMS
GENZYME CORPORATION $17.15 06/05/2024 Food and Beverage Undisputed 01/23/2026 1139805298 CMS
GENZYME CORPORATION $28.10 08/20/2024 Food and Beverage Undisputed 01/23/2026 1139805324 CMS
GlaxoSmithKline, LLC. $23.24 01/23/2024 Food and Beverage Undisputed 01/23/2026 1116596777 CMS
GlaxoSmithKline, LLC. $0.76 01/23/2024 Food and Beverage Undisputed 01/23/2026 1116625522 CMS
GlaxoSmithKline, LLC. $6.88 02/20/2024 Food and Beverage Undisputed 01/23/2026 1116479331 CMS
GlaxoSmithKline, LLC. $28.21 03/22/2024 Food and Beverage Undisputed 01/23/2026 1116638718 CMS
GlaxoSmithKline, LLC. $26.38 04/04/2024 Food and Beverage Undisputed 01/23/2026 1116251128 CMS
GlaxoSmithKline, LLC. $2.90 04/05/2024 Food and Beverage Undisputed 01/23/2026 1116715899 CMS
GlaxoSmithKline, LLC. $25.04 04/30/2024 Food and Beverage Undisputed 01/23/2026 1115734452 CMS
GlaxoSmithKline, LLC. $1.08 04/30/2024 Food and Beverage Undisputed 01/23/2026 1116379198 CMS
GlaxoSmithKline, LLC. $25.76 05/29/2024 Food and Beverage Undisputed 01/23/2026 1116409203 CMS
GlaxoSmithKline, LLC. $1.03 05/29/2024 Food and Beverage Undisputed 01/23/2026 1116731746 CMS
GlaxoSmithKline, LLC. $25.35 06/27/2024 Food and Beverage Undisputed 01/23/2026 1116303257 CMS
GlaxoSmithKline, LLC. $0.93 07/23/2024 Food and Beverage Undisputed 01/23/2026 1115958675 CMS
GlaxoSmithKline, LLC. $26.22 07/23/2024 Food and Beverage Undisputed 01/23/2026 1116087481 CMS
GlaxoSmithKline, LLC. $3.73 07/23/2024 Food and Beverage Undisputed 01/23/2026 1116654089 CMS
GlaxoSmithKline, LLC. $21.62 08/01/2024 Food and Beverage Undisputed 01/23/2026 1116554013 CMS
GlaxoSmithKline, LLC. $6.61 08/23/2024 Food and Beverage Undisputed 01/23/2026 1116154632 CMS
GlaxoSmithKline, LLC. $8.01 09/20/2024 Food and Beverage Undisputed 01/23/2026 1116247046 CMS
GlaxoSmithKline, LLC. $24.29 10/16/2024 Food and Beverage Undisputed 01/23/2026 1116148483 CMS
GlaxoSmithKline, LLC. $0.71 10/16/2024 Food and Beverage Undisputed 01/23/2026 1116658083 CMS
GlaxoSmithKline, LLC. $30.99 12/12/2024 Food and Beverage Undisputed 01/23/2026 1116388910 CMS
Inspire Medical Systems, Inc. $23.54 12/09/2024 Food and Beverage Undisputed 01/23/2026 1148106538 CMS
Mylan Specialty L.P. $41.83 01/10/2024 Food and Beverage Undisputed 01/23/2026 1147308441 CMS
Mylan Specialty L.P. $25.22 04/02/2024 Food and Beverage Undisputed 01/23/2026 1147340794 CMS
Mylan Specialty L.P. $27.73 12/10/2024 Food and Beverage Undisputed 01/23/2026 1147364444 CMS
Philips North America LLC $18.42 09/19/2024 Food and Beverage Undisputed 01/23/2026 1146886250 CMS
Pulmonx Corporation $3.77 01/24/2024 Food and Beverage Undisputed 01/23/2026 1087850832 CMS
Pulmonx Corporation $19.55 01/24/2024 Food and Beverage Undisputed 01/23/2026 1087850834 CMS
Pulmonx Corporation $126.54 10/03/2024 Food and Beverage Undisputed 01/23/2026 1087850836 CMS
Xeris Pharmaceuticals, Inc. $22.06 08/19/2024 Food and Beverage Undisputed 01/23/2026 1144600528 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.